Polyplus-transfection
Latest round
- Series D
Last raised
- Jul 2013
Total raised
- $5.8M
Investors
- 6
About Polyplus-transfection
Founded in 2001 in France, Polyplus-transfection SA is dedicated to developing high-performance transfection solutions for the biotechnology sector.4 billion on March 31, 2023.Polyplus® offers a wide range of transfection reagents, including FectoVIR® for lentiviral and AAV vector production, and in vivo-jetRNA®+ for mRNA delivery. Their products are designed to enhance transfection efficiency and are used primarily by biopharmaceutical companies and research institutions.The recent acquisition by Sartorius AG positions Polyplus-transfection SA to enhance its offerings for cell and gene therapy companies. The acquisition is expected to facilitate expansion into new markets and bolster product development initiatives.
Who invested in Polyplus-transfection
6 investors across 3 rounds
See all investors in Polyplus-transfection
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Polyplus-transfection
Who invested in Polyplus-transfection?
Polyplus-transfection has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Polyplus-transfection raised?
Polyplus-transfection has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Polyplus-transfection last raise money?
Polyplus-transfection's most recent round on record is a Series D, in Jul 2013.
What does Polyplus-transfection do?
Founded in 2001 in France, Polyplus-transfection SA is dedicated to developing high-performance transfection solutions for the biotechnology sector.
Where is Polyplus-transfection headquartered?
Polyplus-transfection is headquartered in France.
Which VCs invest in companies like Polyplus-transfection?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Polyplus-transfection's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Polyplus-transfection? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.